Metropolitan Life Insurance Company (MetLife)’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-4,590
| Closed | -$33.7K | – | 736 |
|
2024
Q1 | $33.7K | Buy |
4,590
+2,446
| +114% | +$18K | ﹤0.01% | 1598 |
|
2023
Q4 | $8.02K | Sell |
2,144
-2,381
| -53% | -$8.91K | ﹤0.01% | 2242 |
|
2023
Q3 | $9.59K | Hold |
4,525
| – | – | ﹤0.01% | 2229 |
|
2023
Q2 | $21.5K | Hold |
4,525
| – | – | ﹤0.01% | 1892 |
|
2023
Q1 | $25.8K | Sell |
4,525
-447
| -9% | -$2.55K | ﹤0.01% | 1749 |
|
2022
Q4 | $50.2K | Hold |
4,972
| – | – | ﹤0.01% | 1469 |
|
2022
Q3 | $111K | Hold |
4,972
| – | – | 0.01% | 950 |
|
2022
Q2 | $123K | Hold |
4,972
| – | – | 0.01% | 941 |
|
2022
Q1 | $193K | Sell |
4,972
-16,007
| -76% | -$621K | 0.01% | 837 |
|
2021
Q4 | $1.23M | Sell |
20,979
-865
| -4% | -$50.6K | 0.02% | 836 |
|
2021
Q3 | $1.29M | Buy |
21,844
+238
| +1% | +$14.1K | 0.02% | 785 |
|
2021
Q2 | $1.88M | Buy |
21,606
+1,363
| +7% | +$118K | 0.03% | 558 |
|
2021
Q1 | $1.67M | Buy |
20,243
+298
| +1% | +$24.6K | 0.02% | 613 |
|
2020
Q4 | $1.81M | Sell |
19,945
-828
| -4% | -$75.3K | 0.03% | 526 |
|
2020
Q3 | $830K | Buy |
20,773
+1,657
| +9% | +$66.2K | 0.01% | 852 |
|
2020
Q2 | $656K | Buy |
19,116
+686
| +4% | +$23.5K | 0.01% | 1022 |
|
2020
Q1 | $409K | Sell |
18,430
-1,170
| -6% | -$26K | 0.01% | 1172 |
|
2019
Q4 | $384K | Hold |
19,600
| – | – | 0.01% | 1492 |
|
2019
Q3 | $304K | Sell |
19,600
-823
| -4% | -$12.8K | 0.01% | 1604 |
|
2019
Q2 | $415K | Hold |
20,423
| – | – | 0.01% | 1425 |
|
2019
Q1 | $359K | Hold |
20,423
| – | – | 0.01% | 1509 |
|
2018
Q4 | $262K | Buy |
20,423
+3,956
| +24% | +$50.8K | 0.01% | 1631 |
|
2018
Q3 | $268K | Hold |
16,467
| – | – | ﹤0.01% | 1806 |
|
2018
Q2 | $187K | Buy |
16,467
+668
| +4% | +$7.58K | ﹤0.01% | 1986 |
|
2018
Q1 | $154K | Buy |
+15,799
| New | +$154K | ﹤0.01% | 2054 |
|